Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.06. | AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial | 592 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L) said that results from the ECHO Phase III trial showed the company's Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated... ► Artikel lesen | |
16.06. | Roche: Phase III Study Of Columvi Combo Extends Survival In Relapsed Diffuse Large B-Cell Lymphoma | 752 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) announced statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi (glofitamab) in combination with... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.795 |
EVOTEC | 2.370 |
TUI | 2.051 |
ASML | 2.000 |
VARTA | 1.725 |
NEL | 1.592 |
BAYER | 1.422 |
BYD | 1.405 |
SUPER MICRO COMPUTER | 1.339 |
TSMC | 819 |
TESLA | 773 |
DEUTSCHE LUFTHANSA | 676 |
COMMERZBANK | 652 |
DEUTSCHE BANK | 646 |
JINKOSOLAR | 622 |
NETFLIX | 582 |
NESTLE | 570 |
AIXTRON SE | 542 |
VOLKSWAGEN | 518 |
RHEINMETALL | 501 |
RWE | 488 |
DEUTSCHE TELEKOM | 474 |
BARRICK GOLD | 471 |
JENOPTIK | 466 |
BASF | 456 |